ArticleFrontiers in immunology2024

Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort study.

Frederik Novak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.